The Colombian National Food and Drug Surveillance Institute (Invima) is developing a reform plan aimed at modernizing its sanitary evaluation and authorization processes. The initiative seeks to decrease current administrative delays and streamline the registration of medications and other health-related products within the country.
A central component of this proposed strategy involves the integration of evaluations conducted by foreign regulatory agencies. By leveraging international assessments, the agency intends to expedite domestic approval timelines and improve the overall efficiency of its regulatory framework.
In-depth summary · AI, neutral